Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy. - Chen Y; Liu Y; Nguyen K; Wu J; Song S; Lin K; Rodrigues PF; Du S; Zhou C; Xiong K; Bosch M; Lin PB; et al. (Science (New York, N.Y.), 2026)